Speakers: Lena Friberg & Elisabet Nielsen, Department of Pharmaceutical Biosciences, Uppsala University, Sweden

Moderator: Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria

In this webinar, Lena Friberg and Elisabet Nielsen discussed:

  1. Population PK modelling to characterize drug exposure and variability
  2. PKPD-modelling to characterize preclinical time-kill data
  3. PKPD-modelling for translation to patients
  4. Model-based dose-individualization

This live webinar including interactive Q&A session was broadcast on 20 August 2019.

If you have questions or comments, please let us know: revive@gardp.org.